drugset / Trial / NCT04565197

Convalescent Plasma Therapy for COVID-19 Patients

NCT04565197

Phase 0 Unknown 20 enrolled Lahore General Hospital
NaSingle-groupOpen-labelTreatment

Summary

Passive immunization involves the administration of antibodies against a given agent to a susceptible individual for the purpose of preventing or treating an infectious disease due to that agent. A general principle of passive antibody therapy is that it is more effective when used for prophylaxis than for treatment of disease. When used for therapy, antibody is most effective when administered shortly after the onset of symptoms

Timeline

Start
2020-05-01
Primary completion
2020-12-30
Completion
2020-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Convalescent Plasma Protein / enzyme biologic 200 ml Other

Indications